Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Donadieu

Showing results (31-40 of 174) with videos related to

Pageof 18
Sort By:
Data in Brief|October 3, 2022
The international dataset on the association between Langerhans Cell Histiocytosis and other malignanciesFrancesca Bagnasco, Stefanie-Yvonne Zimmermann, Rudolph Maarten Egeler, et al.
Pediatric Blood & Cancer|February 1, 2014
Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutationsGaëlle Roques, Martine Munzer, Marie-Anne Carpentier Barthez, et al.
The Journal of Pediatrics|July 4, 2012
Tetralogy of fallot is an uncommon manifestation of warts, hypogammaglobulinemia, infections, and myelokathexis syndromeRaffaele Badolato, Laura Dotta, Laura Tassone, et al.
Pediatrics|March 3, 2006
Cumulative effective doses delivered by radiographs to preterm infants in a neonatal intensive care unitJean Donadieu, Abdelkrim Zeghnoun, Candice Roudier, et al.
European Journal of Endocrinology|July 4, 2019
Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans cell histiocytosisYempabou Sagna, Carine Courtillot, Joseph Y Drabo, et al.
Pediatric Blood & Cancer|June 10, 2021
Cutaneous adverse events in children treated with vemurafenib for refractory BRAF<sup>V600E</sup> mutated Langerhans cell histiocytosisMathilde Tardieu, Amélie Néron, Sophie Duvert-Lehembre, et al.
Pediatric Blood & Cancer|September 5, 2009
2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte SocietySheila Weitzman, Jorge Braier, Jean Donadieu, et al.
Molecular and Cellular Biology|July 20, 2007
Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5Zhijun Duan, Richard E Person, Hu-Hui Lee, et al.
Haematologica|April 10, 2010
Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 casesBenoît Bareau, Jérôme Rey, Mohamed Hamidou, et al.
Lancet (London, England)|April 26, 2021
HistiocytosisJean-François Emile, Fleur Cohen-Aubart, Matthew Collin, et al.
Pageof 18

Showing results (31-40 of 174) with videos related to

Sort By:
Pageof 18
Data in Brief|October 3, 2022
The international dataset on the association between Langerhans Cell Histiocytosis and other malignanciesFrancesca Bagnasco, Stefanie-Yvonne Zimmermann, Rudolph Maarten Egeler, et al.
Pediatric Blood & Cancer|February 1, 2014
Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutationsGaëlle Roques, Martine Munzer, Marie-Anne Carpentier Barthez, et al.
The Journal of Pediatrics|July 4, 2012
Tetralogy of fallot is an uncommon manifestation of warts, hypogammaglobulinemia, infections, and myelokathexis syndromeRaffaele Badolato, Laura Dotta, Laura Tassone, et al.
Pediatrics|March 3, 2006
Cumulative effective doses delivered by radiographs to preterm infants in a neonatal intensive care unitJean Donadieu, Abdelkrim Zeghnoun, Candice Roudier, et al.
European Journal of Endocrinology|July 4, 2019
Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans cell histiocytosisYempabou Sagna, Carine Courtillot, Joseph Y Drabo, et al.
Pediatric Blood & Cancer|June 10, 2021
Cutaneous adverse events in children treated with vemurafenib for refractory BRAF<sup>V600E</sup> mutated Langerhans cell histiocytosisMathilde Tardieu, Amélie Néron, Sophie Duvert-Lehembre, et al.
Pediatric Blood & Cancer|September 5, 2009
2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte SocietySheila Weitzman, Jorge Braier, Jean Donadieu, et al.
Molecular and Cellular Biology|July 20, 2007
Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5Zhijun Duan, Richard E Person, Hu-Hui Lee, et al.
Haematologica|April 10, 2010
Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 casesBenoît Bareau, Jérôme Rey, Mohamed Hamidou, et al.
Lancet (London, England)|April 26, 2021
HistiocytosisJean-François Emile, Fleur Cohen-Aubart, Matthew Collin, et al.
Pageof 18